Daptomycin versus Glycopeptides for the Treatment of <i>Enterococcus faecium</i> Bacteraemia: A Cohort Study

• Egile Nagusiak: Daniel Echeverría-Esnal (Egilea), Luisa Sorli (Egilea), Nuria Prim (Egilea), Clara Martin-Ontiyuelo (Egilea), Juan Pablo Horcajada (Egilea), Santiago Grau (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2021-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Ampicillin resistant and glycopeptide susceptible <i>Enterococcus faecium</i> bloodstream infection (GSEF-BSI) incidence has risen. However, the treatment of choice remains unknown. Daptomycin use for the treatment of enterococcal infections has increased, despite effectivene...